← FDA Drug Approvals (Drugs@FDA)

PIMECROLIMUS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS UT INC · Approved 2018-12-27

Drug application

FDA Application #

ANDA209345

Application type

Abbreviated New Drug Application (Generic)

Brand name

PIMECROLIMUS

Generic name

PIMECROLIMUS

Active ingredients

PIMECROLIMUS

Dosage form

CREAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

ACTAVIS LABS UT INC

Manufacturer

Actavis Pharma, Inc.

First approval

2018-12-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown